"Affinity is the only company that allows for life-enhancing drug therapy to be control-released, customized, and calibrated to necessary levels for treatment or prevention. That means through our proprietary technology platform, therapeutics can be released in the body specifically based on the individual's needs—whether it's within a matter of days or across several months."
"This groundbreaking, tunable, sustainable drug release platform has Affinity poised to create new paths of innovation within numerous medical fields, including regenerative medicine, oncology, and advanced wound therapy."
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze